查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853914

產後出血治療器材市場（依器械類型、應用、最終用戶和分銷管道分類）－全球預測，2025-2032年

Postpartum Hemorrhage Treatment Devices Market by Device Type, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，產後出血治療設備市場規模將達到 14.232 億美元，複合年成長率為 6.48%。

關鍵市場統計數據
基準年 2024 8.6094億美元
預計年份：2025年 9.1691億美元
預測年份 2032 14.232億美元
複合年成長率 (%) 6.48%

本書全面介紹了影響產後出血裝置創新和應用的動態因素、臨床需求和結構性因素。

產後出血仍然是全球最緊急的產科急症之一，而器械輔助治療已成為臨床醫生套件中的重要工具。近年來，臨床實踐強調快速識別、標準化流程以及策略性地部署能夠支援止血並同時維護產婦尊嚴和生育能力的器械。在此背景下，製造商加快了產品研發週期並完善了監管申報流程，醫療系統也重新評估了採購重點，以優先選擇具有明確臨床價值和運作穩定性的器材。

本節從一般觀察著手，逐步過渡到實務層面，將產後急救設備置於更廣泛的孕產婦健康創新背景下進行探討。文章討論了影響需求的臨床因素，包括某些地區剖腹產率的上升、不斷變化的產程管理實踐以及對品質指標日益成長的重視。此外，文章還重點闡述了設備性能特徵、在高壓環境下的易用性以及與現有臨床工作流程的兼容性之間的相互關係。最後，引言概述了影響相關人員如何優先考慮預防和治療方式投資的結構性因素——政策、供應鏈和支付方動態——為後續章節奠定了基礎。

臨床實務的轉變、監管政策的明確化和技術的融合如何重塑產後出血的器械研發和治療模式

產後出血治療器材領域正經歷一場變革，從臨床實踐到監管規範的明確性以及技術的融合。臨床醫生越來越傾向於選擇兼具簡單性和強效止血性能的解決方案，這推動了子宮球囊填塞術和新型快速床邊止血劑的發展。同時，電外科平台和縫合系統的進步彌補了二次出血處理中一些特定的操作缺陷，而彈性繃帶系統則在轉運和固定過程中提供了額外的機械支撐。

除了產品層面的創新，醫療服務模式也正在改變。床邊決策支援、基於模擬的培訓以及能夠縮短干預時間的綜合護理路徑正在醫院和門診環境中整合。監管機構正在明確迭代式設備改進和真實世界證據產生的路徑，加速漸進式創新產品的市場准入，並促進上市後監測合作。總而言之，這些發展正在建立一個更模組化和互通的生態系統，在這個系統中，製造商、醫療服務提供者和支付者必須在整個孕產婦保健過程中合作，才能實現更好的治療效果。

評估2025年美國關稅對設備採購、生產佈局和採購韌性的營運和供應鏈影響

美國關稅將於2025年生效，由此引入的貿易政策層面為設備製造商和醫療服務提供者的供應鏈架構和籌資策略帶來了新的考量。短期內，依賴跨國零件採購的公司面臨不斷上漲的到岸成本，迫使它們重新考慮供應商多元化、安全庫存策略和近岸外包方案，以保持價格競爭力。這些商業應對措施也促使供應商重新審視其合約框架，並尋求更長期的協議，以確保關鍵設備的穩定供應。

除了直接的成本壓力外，關稅也在影響企業在製造地和監管協調方面的策略決策。一些公司加快了對國內製造和本地組裝的投資，以減輕關稅的影響；而另一些公司則優先考慮設計變更，以減少對受關稅影響的原料的依賴。因此，採購團隊越來越關注產品的全生命週期，包括設備耐用性、消毒流程以及對影響營運連續性的耗材的依賴程度。展望未來，累積政策訊號強調供應鏈的韌性和適應性，促使企業重新關注供應商品質、雙源採購策略以及根據關稅波動快速調整物流的能力。

基於精細細分的洞察，包括設備類型、臨床用途、終端用戶行為和通路，定義了採用動態和採購選項。

透過細緻的細分視角，我們可以發現不同器械類別、應用、最終用戶和通路在器械的採納率、臨床效用和商業策略方面存在差異。按器械類型分類，彈性繃帶系統（包括腹部加壓繃帶和骨盆固定帶）因其能夠即時提供機械穩定性，且易於在院前和院間轉運中使用而備受青睞；電外科器械分為雙極和單極兩種平台，有助於控制手術出血。止血劑種類繁多，從膠原蛋白和明膠基製劑到粉狀和海綿狀製劑，應有盡有。縫合系統包括用於快速子宮修復的預製縫合器械和用於最終手術治療的標準縫合套件。子宮球囊填塞解決方案，無論是現成的填塞球囊或低成本的避孕套式填塞裝置，都能為資源不同的環境提供擴充性的選擇。

預防和治療在應用層面的差異會影響臨床醫師選擇設備和製定診療路徑的方式。預防策略優先考慮能夠降低嚴重出血發生率的設備和通訊協定，而治療策略則強調出血發生後快速有效地控制出血。具備全面外科手術能力和血庫支援的醫院傾向於整合更完善的電外科和縫合系統，而診所和門診手術中心則優先考慮便攜、易於培訓且耗材依賴性低的設備。銷售管道進一步影響產品的市場進入和市場推廣。直銷關係能夠提供捆綁式培訓和服務契約，在線銷售擴大了標準化產品的覆蓋範圍，而第三方經銷商有助於在物流和法規環境複雜的地區獲得產品。總而言之，這種市場細分揭示了臨床需求、營運能力和商業策略的交匯點，從而影響產品優先順序和採購行為。

美洲、歐洲、中東和非洲以及亞太地區的區域動態如何影響產後出血治療設備的取得、報銷和臨床應用

區域動態對醫療器材的可及性、報銷和臨床實踐模式有著顯著影響，每個宏觀區域都為相關人員帶來了獨特的機會和挑戰。在美洲，許多醫療系統先進的基礎設施支持了更複雜醫療器材的快速普及，但由於支付方組成、醫院認證要求以及農村地區就醫難等問題，仍然存在顯著的異質性。一些市場的報銷機制和基於價值的舉措獎勵了那些能夠顯著降低併發症發生率和縮短住院時間的干涉措施，從而推動了對可整合到標準化止血方案中的醫療器械的投資。

在歐洲、中東和非洲，監管環境健全的國家與資源匱乏的國家之間有顯著差異。資源匱乏地區對低成本、易於部署的解決方案（例如避孕套式衛生棉條和攜帶式壓迫系統）的需求日益成長。亞太地區則呈現出基礎設施快速發展、法規環境多樣化以及日益重視在地化生產和技術轉移的動態組合。官民合作關係和政府主導的採購計畫加速了該地區的規模化發展，而文化和培訓因素則影響著醫療器材的選擇和臨床培訓策略。在所有地區，相關人員必須適應當地的實務規範、監管要求和物流實際情況，以確保醫療設備能夠送達最需要的地方，並發揮其最大作用。

競爭與策略洞察揭示了創新、夥伴關係和證據生成如何塑造差異化和成長機會。

產後出血醫療器材領域的競爭動態體現了漸進式創新、策略夥伴關係以及擴大臨床應用途徑之間的平衡。大型企業正投資於臨床證據的累積、上市後註冊研究以及旨在加快第一線臨床醫生勝任能力提升的培訓計畫。同時，新興企業則專注於細分市場解決方案，例如低成本的填塞物和新型止血配方，以滿足資源匱乏地區尚未滿足的需求。醫療設備公司與學術中心或醫療系統之間的夥伴關係日益增多，這正推動著真實世界臨床試驗的開展，從而增強產品的價值提案並支持醫保報銷。

如今，產品差異化已不再侷限於效能指標，還涵蓋供應鏈穩定性、模組化服務產品和綜合培訓方案。能夠展現出持續的品管、精簡的滅菌和一次性使用方案以及可擴展的培訓模式的公司，將獲得採購團隊的支持。此外，積極與監管機構溝通，建立清晰的證據路徑，並建立在地化生產和分銷能力的公司，可以降低複雜地區的准入門檻。總而言之，這些策略措施將影響企業的競爭定位，並決定哪些企業最有能力推廣能夠顯著降低產後出血相關發生率的解決方案。

為製造商、醫療保健提供者和經銷商提供具有高影響力的策略建議，以加速產品應用、改善治療效果並增強供應鏈韌性。

產業領導者可以採取有針對性的措施，在管控營運和政策風險的同時，加速產品推廣應用並改善臨床療效。製造商應優先考慮情境化設計方法，使產品功能與預期的臨床實際情況相符，並確保設備在人員配備、消毒方法和供給能力的限制下正常運作。同時，投資於可擴展的培訓計畫、基於模擬的課程和數位化支援工具，可以減少推廣應用的障礙，並增強臨床醫生使用預防性和治療性干預措施的信心。從商業性角度來看，建立結合直銷、電子商務和經銷商合作的靈活分銷模式，可以最佳化覆蓋不同終端使用者類型和地理範圍。

採購和臨床負責人應採用總使用成本框架來評估醫療器械方案，除了考慮單位成本外，還應將耗材、培訓、消毒和物流納入考慮。他們還應參與合作契約，例如基於績效的供應協議和批量採購安排，以使製造商的獎勵與臨床結果保持一致。最後，相關人員應採取積極主動的供應鏈彈性措施，例如雙源採購策略和緊急庫存計劃，以減輕政策變化和關稅相關中斷的影響。實施這些建議將有助於使商業性獎勵與臨床優先事項保持一致，並提高產後出血干預措施的永續性。

調查方法，結合主要相關人員參與、證據綜合和迭代檢驗，為分析提供支持。

本分析採用混合研究途徑，整合了主要相關人員參與、有針對性的文獻回顧和嚴謹的證據三角驗證。一級資訊來源包括與臨床醫生、採購專業人員、監管專家和供應鏈經理進行的結構化訪談和定性討論，以了解各環境下的營運實際情況和未滿足的需求。我們將這些相關人員的意見與檢驗儕審查的臨床研究、監管申報文件、器械標籤資訊和公開的政策文件系統地結合起來，從而為臨床和商業性洞察建立了可靠的依證。

分析方法包括對質性研究結果進行主題綜合分析、對設備屬性和應用案例進行比較評估，以及基於情境的供應鏈和政策影響評估。為確保假設和解釋與實際經驗相符，我們與外部臨床顧問和行業專家進行了反覆的回饋檢驗。為確保透明度，我們詳細記錄了資料來源類型、整合標準以及資料可用性方面的任何固有限制。這種嚴謹的調查方法為報告中提出的趨勢、細分洞察和策略建議提供了可靠的解讀依據。

整合關鍵見解和前瞻性要務，協調臨床創新、供應鏈韌性和協作行動，以降低產後出血的發生率

降低產後出血的發生率需要醫療設備、診療路徑和供應鏈設計的協同進步。臨床創新正在推動快速部署、簡化培訓和提升實際療效，這些優先事項正在再形成產品開發和採購決策。政策和貿易動態增加了新的複雜性，迫使相關人員優先考慮供應鏈韌性和適應性籌資策略，以確保不間斷地獲得救生設備。

最終，最具影響力的干涉措施將出現在臨床證據、產品設計和商業性執行與當地醫療服務實際情況相契合的領域。那些投資於嚴謹的證據收集、客製化培訓和靈活分銷的相關人員，將更有利於推廣能夠改善治療效果的解決方案。展望未來，連接製造商、臨床醫生、醫療系統和政策制定者的跨部門合作，對於將設備層面的改善轉化為產後出血相關併發症的持續降低至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在資源匱乏的醫療機構中增加子宮內球囊填塞系統的使用
  • 推廣使用可生物分解的止血海綿來控制產後出血
  • 擴大可攜式超音波設備在產後早期檢測子宮收縮乏力中的應用
  • 人工智慧驅動的風險評估平台出現，用於預測產後出血併發症
  • 利用微導管創新技術擴展子宮動脈栓塞裝置，實現更安全的介入治療
  • 醫療設備製造商與非政府組織合作，向服務不足地區分發產後出血套件
  • 用於快速子宮壓迫和縫合的微創手術器械的普及
  • 用於治療產後出血的藥物輸送和機械壓迫聯合系統的監管核准
  • 開發一種穿戴式失血監測感測器，用於持續追蹤產後出血情況
  • 人們對基於3D成像和患者解剖結構的客製化子宮填塞球囊的興趣日益濃厚

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依設備類型分類的產後出血治療設備市場

  • 彈性繃帶系統
    • 腹部加壓繃帶
    • 骨盆束縛器
  • 電外科設備
    • 雙極元件
    • 單極裝置
  • 止血劑
    • 膠原蛋白類藥物
    • 明膠類藥物
    • 粉末
    • 海綿
  • 縫合系統
    • 預製縫合器械
    • 標準縫合套件
  • 子宮球囊填塞術
    • 市售的填塞氣球
    • 保險套填塞

9. 按應用分類的產後出血治療設備市場

  • 預防
  • 治療

第10章 依最終使用者分類的產後出血治療設備市場

  • 門診手術中心
  • 診所
  • 醫院

第11章 依分銷管道分類的產後出血治療器械市場

  • 直銷
  • 線上銷售
  • 第三方經銷商

第12章 各地區產後出血治療器材市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 產後出血治療器材市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國產後出血治療器材市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Cook Incorporated
    • Teleflex Incorporated
    • Becton, Dickinson and Company
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Merit Medical Systems, Inc.
    • Smiths Group plc
    • Johnson & Johnson Services, Inc.
    • Boston Scientific Corporation
    • ConMed Corporation
Product Code: MRR-DD5AD9F59CCA

The Postpartum Hemorrhage Treatment Devices Market is projected to grow by USD 1,423.20 million at a CAGR of 6.48% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 860.94 million
Estimated Year [2025] USD 916.91 million
Forecast Year [2032] USD 1,423.20 million
CAGR (%) 6.48%

A definitive introduction to postpartum hemorrhage device dynamics, clinical imperatives, and the structural forces shaping innovation and adoption

Postpartum hemorrhage remains one of the most urgent obstetric emergencies worldwide, and device-based interventions have emerged as critical tools in the clinician toolkit. In recent years, clinical practice has emphasized rapid recognition, standardized protocols, and the strategic deployment of devices that support hemostasis while preserving maternal dignity and fertility. Against this backdrop, manufacturers have accelerated product development cycles, regulatory submissions have grown more sophisticated, and health systems have re-evaluated procurement priorities to emphasize devices that deliver clear clinical value and operational resilience.

Moving from general observation to actionable perspective, this section situates postpartum hemorrhage treatment devices within the broader landscape of maternal health innovation. It describes the clinical drivers-such as rising cesarean rates in some regions, evolving labor management practices, and heightened emphasis on quality metrics-that shape demand. It also highlights the interplay between device performance characteristics, ease of use in high-stress scenarios, and compatibility with existing clinical workflows. Finally, the introduction frames the subsequent sections by outlining the structural forces-policy, supply chains, and payer dynamics-that will influence how stakeholders prioritize investments in prevention and treatment modalities.

How converging clinical practice shifts, regulatory clarity, and technology convergence are reshaping postpartum hemorrhage device development and care delivery

The landscape for postpartum hemorrhage devices is undergoing transformative shifts across clinical practice, regulatory pathways, and technology convergence. Clinicians increasingly favor solutions that combine simplicity with robust hemostatic performance, which has catalyzed interest in uterine balloon tamponade options and newer hemostatic agents that can be deployed rapidly at the bedside. Simultaneously, advances in electrosurgical platforms and suturing systems are addressing specific procedural gaps in secondary hemorrhage management, while elastic bandage systems provide adjunctive mechanical support during transport or stabilization.

Beyond product-level innovation, care delivery models are shifting. Hospitals and ambulatory settings alike are integrating point-of-care decision support, simulation-based training, and bundled care pathways that improve time-to-intervention. Regulatory authorities are clarifying pathways for iterative device improvements and real-world evidence generation, which accelerates market entry for incremental innovations and encourages post-market surveillance partnerships. Taken together, these developments are producing a more modular and interoperable ecosystem in which manufacturers, providers, and payers must coordinate across the continuum of maternal care to realize improvements in outcomes.

Assessing the operational and supply chain repercussions of United States tariffs in 2025 on device sourcing, manufacturing footprint, and procurement resilience

The layer of trade policy introduced by United States tariffs enacted in 2025 has introduced new considerations for supply chain architecture and procurement strategies across device manufacturers and healthcare providers. In the immediate term, firms reliant on cross-border component sourcing have confronted higher landed costs and have had to revisit supplier diversification, safety stock strategies, and nearshoring options to preserve price competitiveness. These operational responses have also prompted providers to re-examine contracting frameworks and to seek longer-term agreements to stabilize access to critical devices.

In addition to direct cost pressures, tariffs have influenced strategic decision-making around manufacturing footprint and regulatory alignment. Some firms have accelerated investments in domestic manufacturing or local assembly to mitigate tariff exposure, while others have prioritized design changes that reduce dependence on tariff-exposed inputs. As a result, procurement teams are increasingly focused on total lifecycle considerations, including device durability, sterilization pathways, and consumable dependencies that affect operational continuity. Looking forward, the cumulative policy signal has emphasized resilience and adaptability in supply chains, driving a renewed focus on supplier quality, dual-sourcing strategies, and the ability to reconfigure logistics rapidly in response to tariff volatility.

Granular segmentation-driven insights into device types, clinical applications, end-user behaviors, and distribution pathways that define adoption dynamics and procurement choices

A nuanced segmentation lens reveals how adoption, clinical utility, and commercial strategies diverge across device categories, applications, end users, and distribution pathways. Within the landscape of device types, elastic bandage systems-encompassing abdominal compression wrapping and pelvic binders-are valued for immediate mechanical stabilization and ease of use in pre-hospital and interfacility transfers, whereas electrosurgical devices, split across bipolar and monopolar platforms, serve in definitive surgical control of bleeding. Hemostatic agents present a broad portfolio that ranges from collagen-based and gelatin-based agents to powders and sponges, each with distinct handling characteristics and suitability for different bleeding etiologies. Suturing systems include prefabricated suturing devices for rapid uterine repair and standard suturing kits for definitive surgical management, and uterine balloon tamponade solutions, whether commercial tamponade balloons or low-cost condom tamponade constructs, offer scaled options for resource-variable settings.

Application-level distinctions between prevention and treatment shape how clinicians select devices and structure care pathways. Preventative strategies prioritize devices and protocols that reduce the incidence of severe hemorrhage, and treatment-oriented use focuses on rapid, effective control once bleeding occurs. End users also create divergent adoption patterns; hospitals with comprehensive surgical capacity and blood bank support will tend to integrate a broader range of electrosurgical and suturing systems, while clinics and ambulatory surgery centers emphasize portability, ease of training, and devices that minimize consumable dependencies. Distribution channels further modulate market access and adoption; direct sales relationships enable bundled training and service agreements, online sales expand reach for standardized products, and third-party distributors facilitate access in regions with complex logistics or regulatory environments. Taken together, segmentation illuminates where clinical need, operational capacity, and commercial strategy intersect to shape product prioritization and procurement behavior.

How regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific shape access, reimbursement, and clinical adoption of postpartum hemorrhage devices

Regional dynamics exert strong influence on device availability, reimbursement, and clinical practice patterns, and each macro-region presents distinct opportunities and constraints for stakeholders. In the Americas, advanced infrastructure in many health systems supports rapid adoption of higher-complexity devices, yet there remains significant heterogeneity driven by payer mix, hospital accreditation requirements, and rural access challenges. Reimbursement mechanisms and value-based initiatives in select markets incentivize interventions that demonstrably reduce complication rates and length of stay, which in turn encourages investment in devices that can be integrated into standardized hemorrhage bundles.

In Europe, Middle East & Africa, the landscape varies considerably between countries with robust regulatory frameworks and those with constrained resources. In higher-resource settings, stringent clinical evaluation and procurement committees demand evidence of comparative effectiveness and cost-efficiency, whereas in resource-limited contexts there is heightened demand for low-cost, highly deployable solutions such as condom tamponade constructs and portable compression systems. Asia-Pacific presents a dynamic mix of rapid infrastructure development, diverse regulatory environments, and an increasing emphasis on local manufacturing and technology transfer. Here, public-private partnerships and government-led procurement programs can accelerate scale-up, while cultural and training considerations influence device selection and clinical training strategies. Across all regions, stakeholders must adapt to local practice norms, regulatory expectations, and logistical realities to ensure devices reach the points of care where they will have the greatest impact.

Competitive and strategic company insights revealing how innovation, partnerships, and evidence-generation shape differentiation and scaling opportunities

Competitive dynamics among companies active in postpartum hemorrhage devices reflect a balance between incremental innovation, strategic partnerships, and pathways to broaden clinical adoption. Leaders are investing in clinical evidence generation, post-market registries, and training programs that reduce time-to-competency for frontline clinicians. At the same time, emerging companies focus on niche solutions-such as low-cost tamponade options or novel hemostatic formulations-that address unmet needs in resource-constrained environments. Partnerships between medical device firms and academic centers or health systems increasingly facilitate real-world studies that strengthen value propositions and support reimbursement discussions.

Product differentiation now extends beyond performance metrics to include supply chain stability, modular service offerings, and integrated training packages. Firms that can demonstrate consistent quality control, streamlined sterilization or single-use options, and scalable training models gain traction with procurement teams. Moreover, companies that proactively engage with regulatory bodies to establish clear evidence pathways and that build localized manufacturing or distribution arrangements can reduce barriers to entry in complex geographies. Collectively, these strategic behaviors influence competitive positioning and determine which organizations are best placed to scale solutions that materially reduce morbidity related to postpartum hemorrhage.

High-impact strategic recommendations for manufacturers, providers, and distributors to accelerate adoption, improve outcomes, and strengthen supply chain resilience

Industry leaders can take targeted actions to accelerate adoption and improve clinical outcomes while managing operational and policy risks. Manufacturers should prioritize design-for-context approaches that align product features with the realities of intended clinical settings, ensuring that devices perform reliably within the constraints of staffing, sterilization practices, and supply availability. Concurrently, investing in scalable training programs, simulation-based curricula, and digital support tools will reduce barriers to adoption and enhance clinician confidence in using both prevention- and treatment-oriented interventions. From a commercial perspective, establishing flexible distribution models that combine direct sales, e-commerce availability, and distributor partnerships can optimize reach across diverse end-user types and geographies.

Procurement and clinical leaders should adopt total-cost-of-use frameworks when evaluating device options, accounting for consumables, training, sterilization, and logistics in addition to unit price. They should also engage in collaborative contracting that aligns manufacturer incentives with clinical outcomes, such as performance-based supply agreements or bundled purchasing arrangements. Finally, stakeholders should pursue proactive supply chain resilience measures, including dual-sourcing strategies and contingency inventory planning, to mitigate the effects of policy shifts and tariff-related disruptions. Implementing these recommendations will help align commercial incentives with clinical priorities and improve the sustainability of postpartum hemorrhage interventions.

Transparent and robust mixed-method research methodology combining primary stakeholder engagement, evidence synthesis, and iterative validation to underpin the analysis

The analysis is grounded in a mixed-methods research approach that integrates primary stakeholder engagement, targeted literature synthesis, and rigorous evidence triangulation. Primary data sources included structured interviews and qualitative consultations with clinicians, procurement specialists, regulatory experts, and supply chain managers to capture operational realities and unmet needs across settings. This stakeholder input was systematically combined with peer-reviewed clinical research, regulatory filings, device labeling information, and publicly available policy documents to establish a robust evidence base for clinical and commercial insights.

Analytical techniques included thematic synthesis of qualitative findings, comparative evaluation of device attributes and use cases, and scenario-based assessment of supply chain and policy impacts. Validation occurred through iterative feedback loops with external clinical advisors and industry experts to ensure that assumptions and interpretations aligned with frontline experience. Transparency measures included detailed documentation of source types, synthesis criteria, and any limitations inherent in data availability. This methodological rigor supports confident interpretation of the trends, segmentation insights, and strategic recommendations presented throughout the report.

Synthesis of pivotal insights and forward-looking imperatives to align clinical innovation, supply chain resilience, and collaborative action in reducing postpartum hemorrhage morbidity

The collective analysis underscores a clear imperative: reducing morbidity from postpartum hemorrhage will require coordinated advances across devices, care pathways, and supply chain design. Clinical innovation is progressing in ways that prioritize rapid deployability, ease of training, and real-world effectiveness, and these priorities are reshaping product development and procurement decisions. Policy and trade dynamics have added a new layer of complexity, compelling stakeholders to prioritize supply chain resilience and adaptive sourcing strategies in order to maintain uninterrupted access to life-saving devices.

Ultimately, the most impactful interventions will arise where clinical evidence, product design, and commercial execution align with local care delivery realities. Stakeholders that invest in rigorous evidence generation, tailored training, and flexible distribution will be best positioned to scale solutions that improve outcomes. Moving forward, cross-sector collaboration-bridging manufacturers, clinicians, health systems, and policymakers-will be essential to translate device-level improvements into sustained reductions in postpartum hemorrhage-related morbidity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing utilization of intrauterine balloon tamponade systems in low-resource healthcare settings
  • 5.2. Accelerated introduction of biodegradable hemostatic sponges for postpartum bleeding control
  • 5.3. Increasing integration of portable ultrasound devices for early detection of uterine atony postpartum
  • 5.4. Emergence of AI-driven risk assessment platforms to predict postpartum hemorrhage complications
  • 5.5. Expansion of uterine artery embolization devices with microcatheter innovations for safer intervention
  • 5.6. Collaborations between device manufacturers and NGOs to distribute PPH kits in underserved regions
  • 5.7. Surge in minimally invasive surgical instruments designed for rapid uterine compression and suturing
  • 5.8. Regulatory approvals of combination drug delivery and mechanical tamponade systems for PPH management
  • 5.9. Development of wearable blood loss monitoring sensors for continuous postpartum hemorrhage tracking
  • 5.10. Growing focus on custom-fit uterine tamponade balloons based on 3D imaging and patient anatomy data

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Postpartum Hemorrhage Treatment Devices Market, by Device Type

  • 8.1. Elastic Bandage Systems
    • 8.1.1. Abdominal Compression Wrapping
    • 8.1.2. Pelvic Binders
  • 8.2. Electrosurgical Devices
    • 8.2.1. Bipolar Devices
    • 8.2.2. Monopolar Devices
  • 8.3. Hemostatic Agents
    • 8.3.1. Collagen Based Agents
    • 8.3.2. Gelatin Based Agents
    • 8.3.3. Powders
    • 8.3.4. Sponges
  • 8.4. Suturing Systems
    • 8.4.1. Prefabricated Suturing Devices
    • 8.4.2. Standard Suturing Kits
  • 8.5. Uterine Balloon Tamponade
    • 8.5.1. Commercial Tamponade Balloon
    • 8.5.2. Condom Tamponade

9. Postpartum Hemorrhage Treatment Devices Market, by Application

  • 9.1. Prevention
  • 9.2. Treatment

10. Postpartum Hemorrhage Treatment Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Clinics
  • 10.3. Hospitals

11. Postpartum Hemorrhage Treatment Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. Online Sales
  • 11.3. Third Party Distributors

12. Postpartum Hemorrhage Treatment Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Postpartum Hemorrhage Treatment Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Postpartum Hemorrhage Treatment Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Cook Incorporated
    • 15.3.2. Teleflex Incorporated
    • 15.3.3. Becton, Dickinson and Company
    • 15.3.4. Baxter International Inc.
    • 15.3.5. B. Braun Melsungen AG
    • 15.3.6. Merit Medical Systems, Inc.
    • 15.3.7. Smiths Group plc
    • 15.3.8. Johnson & Johnson Services, Inc.
    • 15.3.9. Boston Scientific Corporation
    • 15.3.10. ConMed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ABDOMINAL COMPRESSION WRAPPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PELVIC BINDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY BIPOLAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY MONOPOLAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COLLAGEN BASED AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY GELATIN BASED AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY POWDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SPONGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREFABRICATED SUTURING DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY STANDARD SUTURING KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COMMERCIAL TAMPONADE BALLOON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CONDOM TAMPONADE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC AGENTS, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY SUTURING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY UTERINE BALLOON TAMPONADE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELASTIC BANDAGE SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY ELECTROSURGICAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE POSTPARTUM HEMORRHAGE TREATMENT DEVICES MARKET SIZE, BY